3,4-二氨基吡啶

3,4-二氨基吡啶（CAS 54-96-6）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的理化数值

在册的记载用途

Amifampridine is indicated for the symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients. Nevertheless, at the current time only the Firdapse brand of amifampridine is indicated for the treatment of LEMS in both adult and pediatric patients, while the Ruzurgi brand of amifampridine is indicated for the treatment of LEMS only in patients aged 6 to less than 17 years.Amifampridine is an orally available potassium channel blocker that increases acetylcholine in synaptic clefts of peripheral nerve endings and is used to treat the Lambert-Eaton myasthenic syndrome. Amifampridine is associated with a low rate of transient serum enzyme elevations during therapy but has not been linked with instances of clinically apparent acute liver injury.

同义词与商品名

3,4-DIAMINOPYRIDINE; pyridine-3,4-diamine; 54-96-6; Amifampridine; 3,4-Pyridinediamine; 3,4-DAP; 4,5-Diaminopyridine; Pyridine, 3,4-diamino-; SC10; 3,4 Diaminopyridine; amifampridina; DTXSID6046715; RU4S6E2G0J; NSC-521760; DTXCID4026715; 5-22-11-00266 (Beilstein Handbook Reference)

GHS 危害分类

Reported hazard statements	H300 (94.2%), H311 (86.5%), H315 (86.5%), H319 (98.1%), H330 (94.2%), H335 (82.7%)

H300 (94.2%): Fatal if swallowed [Danger Acute toxicity, oral]

H311 (86.5%): Toxic in contact with skin [Danger Acute toxicity, dermal]

公开数据库对它的描述

3,4-Diaminopyridine · CAS 54-96-6 · C5H7N3. UNII RU4S6E2G0J. Melting Point: 229; LogP: -0.5.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。